Reimbursement of diagnostic testing for COVID-19 in Europe

Syndicated report on reimbursement status of IVD tests for COVID-19 as of April 2020 in six European countries

Request a quote

COVID-19 pandemic seriously affected European countries. One of the key aspects of managing the epidemic is the timely testing of potentially infected people. 

This report summarizes the reimbursement situation for COVID-19 in European countries with established reimbursement framework for in-vitro diagnostic tests (Belgium, France, Germany, Netherlands, Switzerland and Turkey).

The 26-page report answers the following question:

  • Is there any reimbursement for IVD testing for COVID-19?
  • What kind of tests (e.g. PCR or serology) are reimbursed?
  • What are the reimbursement tariffs?
  • Are there any restrictions for testing? 

Key features of the report

6 EU countries

Reimbursement situation is summarized in the countries, where specific reimbursement frameworks exist (Belgium, France, Germany, Netherlands, Switzerland, Turkey)

Brief overview of system

Brief overview of reimbursement framework in each country is provided

Reimbursement situation for COVID-19 testing

Reimbursement codes and tariffs, testing restrictions and guidelines

Obtain sample pages

Click to the link below to obtain sample pages, including description of the reimbursement framework and reimbursement situation for COVID-19 in Switzerland

Get sample pages

Sources for analysis

Belgium: IVD tests included in the INAMI Nomenclature 

France: IVD tests included in the NABM and RIHN Nomenclatures 

Germany: IVD tests included in the EBM Nomenclature 

Netherlands: Coverage policies by key insurance companies, decisions of Dutch Healthcare Authority and OZP List

Switzerland: IVD tests included in the List of Analyses (Annex 3 of the KLV List)

Turkey: IVD tests included in the Healthcare Implementation Communique

Request a quote

Click the button below to request a quote for the report


50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.